Evidence map›Paper›PMID 31148979›Full record

ArticleAfrican health sciences2019

A prospective study to compare the effectiveness of adjunctive rectal misoprostol or oxytocin titration in the prevention of primary post-partum haemorrhage in at risk patients.

Rafat Muhammad, Aliyu Isah, Teddy Agida, Godwin Akaba

Open access · diamondAbstract readComparative Study
In one paragraph

Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Differences in obstetric practices and outcomes of postpartum hemorrhage across Nigerian health facilities.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rafat MuhammadUniversity of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria, Obstetrics and Gynaecology.
Aliyu IsahUniversity of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria, Obstetrics and Gynaecology.
Teddy AgidaUniversity of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria, Obstetrics and Gynaecology.
Godwin AkabaUniversity of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria, Obstetrics and Gynaecology.
University of Abuja Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdjunctive uterotonic in patients at risk of primary post-partum haemorrhage may reduce its incidence.

objectiveTo compare the effectiveness and safety of adjunctive rectal misoprostol with adjunctive intravenous oxytocin for the prevention of primary post-partum haemorrhage in at risk patients. MATERIALS AND

methodsA total of 122 patients with risk factors for uterine atony were allocated to receive either 600µg of rectal misoprostol (n= 61) or 20IU of oxytocin infusion (n=61) after routine management of third stage of labour. Post-partum blood loss was measured using differential delivery towel and pad weighing.

resultsThere was similarity in the estimated post-partum blood loss, with no significant difference in the mean post-partum hematocrit levels between the adjunctive rectal misoprostol group and oxytocin infusion group (P=0.712). There was no difference in the need for additional intervention of uterotonics between the two groups. There were however, higher incidences of shivering and pyrexia among those that received misoprostol compared with the oxytocin group.

conclusionRectal misoprostol is as effective and safe as oxytocin when used as an adjunctive uterotonic in preventing primary post-partum haemorrhage in patients with risk factors for uterine atony after active management of third stage of labour.

Indexed as

Administration, IntravenousAdministration, RectalAdultDelivery, ObstetricDrug Administration ScheduleFemaleHumansIncidenceLabor Stage, ThirdMisoprostolOxytocicsOxytocinPostpartum HemorrhagePregnancyRisk FactorsTreatment OutcomeMisoprostolOxytocicsOxytocinAdjunctive rectal misoprostolpatientsprimary post-partum haemorrhage

Identifiers

PMID31148979
PMCPMC6531961
OpenAlexW2940733630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.